NCT06765564View on ClinicalTrials.gov

Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

NARecruitingINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

March 13, 2025

Study Completion Date

May 13, 2025

Conditions

ALS

Interventions

DRUG

iPSC-MNP

Using iPSC-MNP Cells for the Treatment of ALS Patients

Trial Locations (1)

Unknown

RECRUITING

Shang hai East Hospital, Shanghai

All Listed Sponsors

lead

Shanghai East Hospital

OTHER